Oxford Biomedica’s Post

On the fourth day of our festive campaign, we shine a light on the TetraVecta™ system—our 𝟰𝘁𝗵-generation lentiviral vector delivery system.  This next-generation innovation can significantly enhance the development and manufacturing of safer and more effective lentiviral vector-based therapies through improved quality, potency and packaging capacity. View our latest TetraVecta™ System poster to discover how this new technology is paving the way for genuine plug and play manufacturing: https://lnkd.in/ep53JA_H    Join us tomorrow for day 5!    #OXB12Days #LentiviralVectors #ViralVectors #Innovation #CellAndGeneTherapy 

  • OXB’s 4th-generation lentiviral vector delivery system enhances quality, potency, and safety of lentiviral vectors

To view or add a comment, sign in

Explore topics